seed
Stage
1
Investors
About
AEYE Health develops FDA-cleared autonomous AI diagnostic screening systems for diabetic retinopathy that utilize portable and tabletop retinal imaging devices to provide on-the-spot diagnosis without needing physician interpretation.
Explore AEYE Health's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.